(CNN) Last week, Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance
For many Americans who want to lose weight, the desire to start a GLP-1 drug in 2026 exists in theory, but remains contingent on whether the economic barriers to access can be overcome
Laboratory research record on Melatonin [PMID: 41732549] PubMed laboratory record discussing Melatonin in a research context
This modest initial loss reflects the conservative starting dose of 0.25 mg weekly, with more substantial weight loss occurring in subsequent months as the dose increases
In November 2023, tirzepatide was also approved for chronic weight management in adults with obesity or overweight and at least one weight-related comorbidity
Notably, the percentage of basophils ( Figure 3D ) showed a significant group effect (p G = 0.019) in addition to the time effect